283 related articles for article (PubMed ID: 3708774)
21. Electrical heterogeneity and arrhythmogenesis: importance of conduction velocity dispersion.
Sims JJ; Miller AW; Ujhelyi MR
J Cardiovasc Pharmacol; 2003 May; 41(5):795-803. PubMed ID: 12717112
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter.
Ortiz J; Nozaki A; Shimizu A; Khrestian C; Rudy Y; Waldo AL
Circulation; 1994 Jun; 89(6):2860-9. PubMed ID: 8205702
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiologic and antiarrhythmic effects of the new class III antiarrhythmic drug KCB-328 in experimental canine atrial flutter.
Rahme MM; Ungab GA; Wadhwa M; Al-Kandari F; Yao B; Gupta A; Lee K; Kim HY; Feld GK
J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):297-306. PubMed ID: 11584336
[TBL] [Abstract][Full Text] [Related]
24. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
Wang J; Feng J; Nattel S
Circulation; 1994 Oct; 90(4):2032-40. PubMed ID: 7923691
[TBL] [Abstract][Full Text] [Related]
25. Multiple modes of termination of re-entrant excitation around an anatomic barrier in the canine atrium during the action of d-sotalol.
Boyden PA; Graziano JN
Eur Heart J; 1993 Nov; 14 Suppl H():41-9. PubMed ID: 8293753
[TBL] [Abstract][Full Text] [Related]
26. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Inoue H; Zipes DP
Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
Karagueuzian HS; Katoh T; McCullen A; Mandel WJ; Peter T
Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682
[TBL] [Abstract][Full Text] [Related]
28. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Costard-Jäckle A; Franz MR
J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
[TBL] [Abstract][Full Text] [Related]
29. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
[TBL] [Abstract][Full Text] [Related]
30. Comparisons of the electrophysiological effects of intravenous sotalol and propranolol on the immature mammalian heart.
Xu H; Villafane J; McCormack J; Stolfi A; Gelband H; Pickoff AS
J Cardiovasc Pharmacol; 1989 Jun; 13(6):925-9. PubMed ID: 2484088
[TBL] [Abstract][Full Text] [Related]
31. Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model.
Restivo M; Hegazy M; Caref EB; Avitable MJ; Assadi MA; el-Hamami M; Yin H; Piracha M; Brooks RR; el-Sherif N
J Cardiovasc Electrophysiol; 1996 Jul; 7(7):612-24. PubMed ID: 8807407
[TBL] [Abstract][Full Text] [Related]
32. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
Goldstein RN; Khrestian C; Carlsson L; Waldo AL
J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294
[TBL] [Abstract][Full Text] [Related]
33. The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart.
Sato S; Yamauchi S; Schuessler RB; Boineau JP; Matsunaga Y; Cox JL
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):297-306. PubMed ID: 1495290
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
Spinelli W; Hoffman BF
Circ Res; 1989 Dec; 65(6):1565-79. PubMed ID: 2510953
[TBL] [Abstract][Full Text] [Related]
35. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
36. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS
Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087
[TBL] [Abstract][Full Text] [Related]
37. Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol.
Spinelli W; Parsons RW; Colatsky TJ
J Cardiovasc Pharmacol; 1992 Dec; 20(6):913-22. PubMed ID: 1282594
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiologic properties of a narrow isthmus in rabbit atrial tissue: cycle length dependent effect of quinidine.
Qi A; Kerr CR; Yeung-Lai-Wah JA
Can J Physiol Pharmacol; 1994 Apr; 72(4):375-81. PubMed ID: 7922869
[TBL] [Abstract][Full Text] [Related]
39. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
Sheldon RS; Rahmberg M; Duff HJ
J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
[TBL] [Abstract][Full Text] [Related]
40. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
Gomoll AW; Bartek MJ
Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
